Glimepiride Tablet
Product Images NDC 16571-774

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 16571-774). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1 mg (100 Tablet Bottle))

This is a medication called Glimepiride in tablet form, with 1mg strength. The dosage information is available in the package insert. The container should be kept out of reach of children and stored at 20° to 25°C (68° to 77°F). The manufacturer is Rising Pharma Holdings, Inc. and the medication is distributed in the USA. The code is TSDRUGS/222000. The document is dated 08/2021.*

FDA Label Image

Package Label-principal Display Panel (2 mg (100 Tablet Bottle))

Glimepiride is a drug that is available in tablet form and it should be taken once a day. Each bottle contains 100 tablets and each tablet has 2 mg of Glimepiride USP. The package insert should be consulted for dosage information as it can vary. This drug should be kept out of the reach of children and dispensed in a well-closed container with child-resistant closure. It can be stored at 20°C to 25°C (68°F to 77°F) in order to be preserved easily. The code TS/DRUGS/22/2009 was used to identify the drug and it was made in India, while Rising Pharma Holdings, Inc. from East Brunswick was responsible for its distribution in the United States.*

FDA Label Image

Package Label-principal Display Panel (4 mg (100 Tablet Bottle))

Glimepiride is a medication available in the form of tablets that are taken once a day. Each tablet contains 4 mg of Glimepiride USP. Dosage and administration information are available in the package insert. It is important to keep this medication out of the reach of children and to store it in a well-closed container with a child-resistant closure at a temperature of 20° to 25°C (68° to 77°F) per USP controlled room temperature. This medication was made in India with an expiration date of 03/2021 and is distributed by Rising Pharma Holdings, Inc. in East Brunswick, NJ.*

FDA Label Image

Chemical Structure (Glimepiride Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.